Nov 07, 2017 13:02 pm UTC| Business
ANN ARBOR, Mich., Nov. 07, 2017 -- Esperion Therapeutics, Inc. (NASDAQ:ESPR), the Lipid Management Company focused on developing and commercializing convenient, complementary, cost-effective, once-daily, oral therapies...
Nov 07, 2017 13:02 pm UTC| Business
MIAMI, Nov. 07, 2017 -- OPKO Health, Inc. (NASDAQ:OPK) ("OPKO" or "the Company") announces the filing of a Premarket Approval (PMA) application with the U.S. Food and Drug Administration (FDA) for the Total PSA test...
Nov 07, 2017 13:02 pm UTC| Business
Achieved confirmed responses in melanoma patients progressing on PD-1/PD-L1 therapy Expanding Bristol-Myers Squibb clinical collaboration SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 -- Calithera Biosciences, Inc....
Nov 07, 2017 13:01 pm UTC| Business
MINNEAPOLIS, Nov. 07, 2017 -- DiaMedica Therapeutics Inc. (the “Company”) (TSX Venture:DMA) (OTCQB:DMCAF), a clinical stage biopharmaceutical company focused on improving the lives of patients with neurological and...
Celldex Reports Third Quarter 2017 Results
Nov 07, 2017 13:02 pm UTC| Business
HAMPTON, N.J., Nov. 07, 2017 -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported business and financial highlights for the third quarter ended September 30, 2017. "In late August, we completed enrollment in our...
Nov 07, 2017 13:01 pm UTC| Business
LAKE FOREST, Calif., Nov. 07, 2017 -- Baldwin Hardware, a leading brand of the Hardware Home Improvement (HHI) division of Spectrum Brands Holdings (NYSE:SPB), today announced it has named 27 architects and designers...
Atlas Air Worldwide Reports Third-Quarter 2017 Results
Nov 07, 2017 13:01 pm UTC| Business
Significant Revenue and Volume GrowthWarrant Accounting Resulted in Reported Loss from Continuing Operations of $24.2 MillionExcluding Warrant Accounting, Adjusted Income from Continuing Operations Was $29.7 Million After...
UK Inflation Stabilizes: November CPI at 2.6%, Signaling Economic Recovery
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update